Physician profile
Grace Laast Adofo
NPI 1457344269
$2,580.39
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $722 · 2020: $244 · 2021: $444 · 2022: $1,170.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $580.89 | 2019-2022 | |
| Amgen INC. | $236.12 | 2019-2022 | |
| Therapeuticsmd, INC. | $228.80 | 2020-2022 | |
| Daiichi Sankyo INC. | $223.61 | 2019-2022 | |
| Myovant Sciences INC. | $195.67 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $165.01 | 2019-2022 | |
| Avion Pharmaceuticals | $113.63 | 2019-2022 | |
| Pfizer INC. | $112.04 | 2019-2022 | |
| Allergan, INC. | $105.00 | 2019-2020 | |
| Exeltis, USA INC. | $100.28 | 2019-2022 | |
| Coopersurgical, INC. | $93.30 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $84.26 | 2019-2020 | |
| Millicent US INC | $67.58 | 2019 | |
| Amag Pharmaceuticals, INC. | $53.45 | 2019-2020 | |
| Hologic Sales and Service, LLC | $41.26 | 2019-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $35.64 | 2019 | |
| Avanos Medical | $23.56 | 2019 | |
| Urovant Sciences INC | $21.75 | 2022 | |
| Duchesnay USA Incorporated | $20.00 | 2019 | |
| Mayne Pharma Commercial LLC | $19.21 | 2022 | |
| Evofem Biosciences, INC. | $18.91 | 2021 | |
| Mission Pharmacal Company | $17.23 | 2019 | |
| Agile Therapeutics, INC. | $12.17 | 2021 | |
| Ferring Pharmaceuticals INC. | $11.02 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Laast Adofo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.